1. Executive Summary 2. Anti-obesity Drugs Market Characteristics
3. Anti-obesity Drugs Market Trends And Strategies
4. Anti-obesity Drugs Market – Macro Economic Scenario
4.1 COVID-19 Impact On Anti-obesity Drugs Market
4.2 Ukraine-Russia War Impact On Anti-obesity Drugs Market
4.3 Impact Of High Inflation On Anti-obesity Drugs Market
5. Anti-obesity Drugs Market Size And Growth
5.1. Global Anti-obesity Drugs Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Anti-obesity Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Anti-obesity Drugs Market Segmentation
6.1. Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Peripherally acting anti obesity drugs
Centrally acting anti obesity drugs
6.2. Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Prescription Drugs (Rx)
OTC Drugs
6.3. Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Monotherapies
Polytherapies
7. Anti-obesity Drugs Market Regional And Country Analysis
7.1. Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Anti-obesity Drugs Market
8.1. Asia-Pacific Anti-obesity Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Anti-obesity Drugs Market
9.1. China Anti-obesity Drugs Market Overview
9.2. China Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Anti-obesity Drugs Market
10.1. India Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Anti-obesity Drugs Market
11.1. Japan Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Anti-obesity Drugs Market
12.1. Australia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Anti-obesity Drugs Market
13.1. Indonesia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Anti-obesity Drugs Market
14.1. South Korea Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Anti-obesity Drugs Market
15.1. Western Europe Anti-obesity Drugs Market Overview
15.2. Western Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Anti-obesity Drugs Market
16.1. UK Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Anti-obesity Drugs Market
17.1. Germany Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Anti-obesity Drugs Market
18.4. France Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.5. France Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Anti-obesity Drugs Market
19.1. Eastern Europe Anti-obesity Drugs Market Overview
19.2. Eastern Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Anti-obesity Drugs Market
20.1. Russia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Anti-obesity Drugs Market
21.1. North America Anti-obesity Drugs Market Overview
21.2. North America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Anti-obesity Drugs Market
22.1. USA Anti-obesity Drugs Market Overview
22.2. USA Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Anti-obesity Drugs Market
23.1. South America Anti-obesity Drugs Market Overview
23.2. South America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Anti-obesity Drugs Market
24.1. Brazil Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Anti-obesity Drugs Market
25.1. Middle East Anti-obesity Drugs Market Overview
25.2. Middle East Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Anti-obesity Drugs Market
26.1. Africa Anti-obesity Drugs Market Overview
26.2. Africa Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Anti-obesity Drugs Market Competitive Landscape And Company Profiles
27.1. Anti-obesity Drugs Market Competitive Landscape
27.2. Anti-obesity Drugs Market Company Profiles
27.2.1. F. Hoffmann-La Roche AG,
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. GlaxoSmithKline PLC.,
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Boehringer Ingelheim GmbH,
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Pfizer Inc.,
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Merck & Co. Inc.,
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Anti-obesity Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Anti-obesity Drugs Market
30. Anti-obesity Drugs Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Historic And Forecast Inflation Rates
31.4. Research Inquiries
31.5. The Business Research Company
31.6. Copyright And Disclaimer